NCT02813226View on ClinicalTrials.gov

Assessment of New Molecular Imaging Strategies for Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 16, 2017

Primary Completion Date

March 20, 2020

Study Completion Date

December 17, 2021

Conditions
Prostate Cancer
Interventions
OTHER

Molecular Imaging

Baseline and follow-up FDG PET-CT and DCFPyL PET-CT

Trial Locations (3)

Unknown

Juravinski Hospital and Cancer Centre, Hamilton

London Health Sciences Centre, London

Sunnybrook-Odette Cancer Centre, Toronto

All Listed Sponsors
lead

Ontario Clinical Oncology Group (OCOG)

OTHER

NCT02813226 - Assessment of New Molecular Imaging Strategies for Prostate Cancer | Biotech Hunter | Biotech Hunter